Newsroom
Sorted by: Latest
-
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference...
-
Valmont Increases Quarterly Dividend by 13%
OMAHA, Neb.--(BUSINESS WIRE)--Valmont® Industries, Inc. (NYSE: VMI), a global leader that provides products and solutions to support vital infrastructure and advance agricultural productivity, today announced that its Board of Directors has approved a 13% increase in the Company’s quarterly cash dividend to $0.77 per share, payable on April 15, 2026 to shareholders of record on March 27, 2026. The increase results in an annualized dividend of $3.08 per share. The dividend increase is consistent...
-
Uber to Acquire Parking App SpotHero
SAN FRANCISCO & CHICAGO--(BUSINESS WIRE)--Uber Technologies, Inc. (NYSE: UBER) and SpotHero, Inc. today announced that they have reached an agreement for Uber to acquire SpotHero, bringing parking reservations onto the Uber app. Since launching in 2011, SpotHero has become the industry-leading parking reservation app, with millions of drivers easily finding affordable parking at more than 13,000 garages, lots, and valets across more than 400 cities in the U.S. and Canada. Uber plans to offer a...
-
Apple Hospitality REIT Reports Results of Operations for Fourth Quarter and Full Year 2025
RICHMOND, Va.--(BUSINESS WIRE)--Apple Hospitality REIT Reports Results of Operations for Fourth Quarter and Full Year 2025...
-
Brighthouse Financial Announces Fourth Quarter and Full Year 2025 Results
CHARLOTTE, N.C.--(BUSINESS WIRE)--Brighthouse Financial, Inc. ("Brighthouse Financial" or the "company") (Nasdaq: BHF) announced today its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Results The company reported net income available to shareholders of $112 million in the fourth quarter of 2025, or $1.93 per diluted share, compared with net income available to shareholders of $646 million in the fourth quarter of 2024, or $10....
-
ImmunityBio Founder Dr. Patrick Soon-Shiong to Speak at Milken Institute and Richard Nixon Foundation "Cancer 2035: A Roadmap for the Future" Summit
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (Nasdaq: IBRX), a commercial-stage biotechnology company pioneering next-generation immunotherapies, today announced that its Founder, Executive Chairman, and Global Chief Scientific and Medical Officer, Dr. Patrick Soon-Shiong, will participate as a featured speaker at "Cancer 2035: A Roadmap for the Future," a landmark summit co-hosted by the Milken Institute and the Richard Nixon Foundation in Washington, D.C. on February 23–24, 2026. T...
-
Ingevity announces upcoming board transitions
NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Founding directors Daniel F. Sansone and Jean S. Blackwell to conclude board service at the Ingevity 2026 Annual Meeting...
-
Puma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology CEO & President Alan Auerbach will provide a corporate overview at the TD Cowen Health Care Conference on March 2 at 2:30 pm ET....
-
Atlas Energy Solutions Announces Fourth Quarter and Year End 2025 Results
AUSTIN, Texas--(BUSINESS WIRE)--Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today reported financial and operating results for the fourth quarter and fiscal year ended December 31, 2025. Year End 2025 Financial Highlights and Operational Updates Revenue of $1.1 billion, net loss of ($50.3) million and Adjusted EBITDA(1) of $221.7 million for the year ended December 31, 2025 Total volumes of 21.6 million tons for the year ended December 31, 2025 Total Dune Express shipmen...
-
Diversified Healthcare Trust Announces Fourth Quarter 2025 Results
NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended December 31, 2025 and provided full year 2026 financial guidance, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. A conference call to discuss DHC's fourth quarter 2025 financial results will be held on Tuesday, February 24, 2026 at 10:00 a.m. Eastern Time. Th...